Related Experiment Videos
Rheumatic diseases and malignancy--is there an association?
Scandinavian Journal of Rheumatology
|October 2, 2001
Summary
Patients with certain autoimmune rheumatic diseases face an increased risk of cancer. Further research is needed to clarify these associations, especially concerning cytotoxic therapy risks.
Area of Science:
- Rheumatology
- Oncology
- Epidemiology
Background:
- Reviews published data on the association between autoimmune rheumatic diseases and malignancy.
- Examines the overall risk of cancer in patients with various autoimmune rheumatic conditions.
Discussion:
- Highlights documented increased cancer risk in Sjögren's syndrome, systemic sclerosis with pulmonary fibrosis, and dermatomyositis/polymyositis.
- Notes a potential increased cancer risk for rheumatoid arthritis patients.
- Addresses the controversial association between systemic lupus erythematosus and malignancy.
Key Insights:
- Specific autoimmune rheumatic diseases are linked to a higher likelihood of developing cancer.
- The relationship between systemic lupus erythematosus and cancer risk requires further investigation.
Outlook:
- Emphasizes the need for more epidemiologic studies to clarify these associations.
- Calls for research into the specific risks associated with cytotoxic therapies in rheumatic disease patients.